메뉴 건너뛰기




Volumn 64, Issue 12, 2012, Pages 1855-1863

Does medication adherence itself confer fracture protection? An investigation of the healthy adherer effect in observational data

Author keywords

[No Author keywords available]

Indexed keywords

BISPHOSPHONIC ACID DERIVATIVE; CALCIUM CHANNEL BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; SEROTONIN UPTAKE INHIBITOR;

EID: 84870490270     PISSN: 2151464X     EISSN: 21514658     Source Type: Journal    
DOI: 10.1002/acr.21759     Document Type: Article
Times cited : (17)

References (30)
  • 1
    • 0032802313 scopus 로고    scopus 로고
    • A review of the healthy worker effect in occupational epidemiology
    • Li CY, Sung FC,. A review of the healthy worker effect in occupational epidemiology. Occup Med (Lond) 1999; 49: 225-9.
    • (1999) Occup Med (Lond) , vol.49 , pp. 225-229
    • Li, C.Y.1    Sung, F.C.2
  • 4
    • 0018962999 scopus 로고
    • Influence of adherence to treatment and response of cholesterol on mortality in the coronary drug project
    • Influence of adherence to treatment and response of cholesterol on mortality in the coronary drug project. N Engl J Med 1980; 303: 1038-41.
    • (1980) N Engl J Med , vol.303 , pp. 1038-1041
  • 5
    • 79954637459 scopus 로고    scopus 로고
    • Placebo adherence, clinical outcomes, and mortality in the women's health initiative randomized hormone therapy trials
    • Curtis JR, Larson JC, Delzell E, Brookhart MA, Cadarette SM, Chlebowski R, et al. Placebo adherence, clinical outcomes, and mortality in the women's health initiative randomized hormone therapy trials. Med Care 2011; 49: 427-35.
    • (2011) Med Care , vol.49 , pp. 427-435
    • Curtis, J.R.1    Larson, J.C.2    Delzell, E.3    Brookhart, M.A.4    Cadarette, S.M.5    Chlebowski, R.6
  • 6
    • 79953039796 scopus 로고    scopus 로고
    • The relationship between bisphosphonate adherence and fracture: Is it the behavior or the medication? Results from the placebo arm of the Fracture Intervention Trial
    • Curtis JR, Delzell E, Chen L, Black D, Ensrud K, Judd S, et al. The relationship between bisphosphonate adherence and fracture: is it the behavior or the medication? Results from the placebo arm of the Fracture Intervention Trial. J Bone Miner Res 2011; 26: 683-8.
    • (2011) J Bone Miner Res , vol.26 , pp. 683-688
    • Curtis, J.R.1    Delzell, E.2    Chen, L.3    Black, D.4    Ensrud, K.5    Judd, S.6
  • 7
    • 77953476723 scopus 로고    scopus 로고
    • Poor bisphosphonate adherence for treatment of osteoporosis increases fracture risk: Systematic review and meta-analysis
    • Imaz I, Zegarra P, Gonzalez-Enriquez J, Rubio B, Alcazar R, Amate JM,. Poor bisphosphonate adherence for treatment of osteoporosis increases fracture risk: systematic review and meta-analysis. Osteoporos Int 2010; 21: 1943-51.
    • (2010) Osteoporos Int , vol.21 , pp. 1943-1951
    • Imaz, I.1    Zegarra, P.2    Gonzalez-Enriquez, J.3    Rubio, B.4    Alcazar, R.5    Amate, J.M.6
  • 8
    • 58949097888 scopus 로고    scopus 로고
    • Impact of osteoporosis treatment adherence on fracture rates in North America and Europe
    • Siris ES, Selby PL, Saag KG, Borgstrom F, Herings RM, Silverman SL,. Impact of osteoporosis treatment adherence on fracture rates in North America and Europe. Am J Med 2009; 122 Suppl: S3-13.
    • (2009) Am J Med , vol.122 , Issue.SUPPL.
    • Siris, E.S.1    Selby, P.L.2    Saag, K.G.3    Borgstrom, F.4    Herings, R.M.5    Silverman, S.L.6
  • 9
    • 50249133642 scopus 로고    scopus 로고
    • The benefit of adherence with bisphosphonates depends on age and fracture type: Results from an analysis of 101,038 new bisphosphonate users
    • Curtis JR, Westfall AO, Cheng H, Lyles K, Saag KG, Delzell E,. The benefit of adherence with bisphosphonates depends on age and fracture type: results from an analysis of 101,038 new bisphosphonate users. J Bone Miner Res 2008; 23: 1435-41.
    • (2008) J Bone Miner Res , vol.23 , pp. 1435-1441
    • Curtis, J.R.1    Westfall, A.O.2    Cheng, H.3    Lyles, K.4    Saag, K.G.5    Delzell, E.6
  • 10
    • 0142157169 scopus 로고    scopus 로고
    • Evaluating medication effects outside of clinical trials: New-user designs
    • Ray WA,. Evaluating medication effects outside of clinical trials: new-user designs. Am J Epidemiol 2003; 158: 915-20.
    • (2003) Am J Epidemiol , vol.158 , pp. 915-920
    • Ray, W.A.1
  • 11
    • 0032474241 scopus 로고    scopus 로고
    • Use of selective serotonin receptor uptake inhibitors or tricyclic antidepressants and risk of hip fractures in elderly people
    • Liu B, Anderson G, Mittmann N, To T, Axcell T, Shear N,. Use of selective serotonin receptor uptake inhibitors or tricyclic antidepressants and risk of hip fractures in elderly people. Lancet 1998; 351: 1303-7.
    • (1998) Lancet , vol.351 , pp. 1303-1307
    • Liu, B.1    Anderson, G.2    Mittmann, N.3    To, T.4    Axcell, T.5    Shear, N.6
  • 12
    • 34347220867 scopus 로고    scopus 로고
    • Use of antidepressants and rates of hip bone loss in older women: The study of osteoporotic fractures
    • Diem SJ, Blackwell TL, Stone KL, Yaffe K, Haney EM, Bliziotes MM, et al. Use of antidepressants and rates of hip bone loss in older women: the study of osteoporotic fractures. Arch Intern Med 2007; 167: 1240-5.
    • (2007) Arch Intern Med , vol.167 , pp. 1240-1245
    • Diem, S.J.1    Blackwell, T.L.2    Stone, K.L.3    Yaffe, K.4    Haney, E.M.5    Bliziotes, M.M.6
  • 13
    • 39349086278 scopus 로고    scopus 로고
    • Systematic review: Comparative effectiveness of treatments to prevent fractures in men and women with low bone density or osteoporosis
    • MacLean C, Newberry S, Maglione M, McMahon M, Ranganath V, Suttorp M, et al. Systematic review: comparative effectiveness of treatments to prevent fractures in men and women with low bone density or osteoporosis. Ann Intern Med 2008; 148: 197-213.
    • (2008) Ann Intern Med , vol.148 , pp. 197-213
    • MacLean, C.1    Newberry, S.2    Maglione, M.3    McMahon, M.4    Ranganath, V.5    Suttorp, M.6
  • 14
    • 84857370715 scopus 로고    scopus 로고
    • Selective serotonin reuptake inhibitor treatment and risk of fractures: A meta-analysis of cohort and case-control studies
    • Wu Q, Bencaz AF, Hentz JG, Crowell MD,. Selective serotonin reuptake inhibitor treatment and risk of fractures: a meta-analysis of cohort and case-control studies. Osteoporos Int 2012; 23: 365-75.
    • (2012) Osteoporos Int , vol.23 , pp. 365-375
    • Wu, Q.1    Bencaz, A.F.2    Hentz, J.G.3    Crowell, M.D.4
  • 15
    • 79959501657 scopus 로고    scopus 로고
    • Risk of fractures in older adults using antihypertensive medications
    • Solomon DH, Mogun H, Garneau K, Fischer MA,. Risk of fractures in older adults using antihypertensive medications. J Bone Miner Res 2011; 26: 1561-7.
    • (2011) J Bone Miner Res , vol.26 , pp. 1561-1567
    • Solomon, D.H.1    Mogun, H.2    Garneau, K.3    Fischer, M.A.4
  • 16
    • 85027958967 scopus 로고    scopus 로고
    • Antidepressants and fracture risk in older adults: A comparative safety analysis
    • Gagne JJ, Patrick AR, Mogun H, Solomon DH,. Antidepressants and fracture risk in older adults: a comparative safety analysis. Clin Pharmacol Ther 2011; 89: 880-7.
    • (2011) Clin Pharmacol Ther , vol.89 , pp. 880-887
    • Gagne, J.J.1    Patrick, A.R.2    Mogun, H.3    Solomon, D.H.4
  • 17
    • 32944477369 scopus 로고    scopus 로고
    • Treatment with β-blockers, ACE inhibitors, and calcium-channel blockers is associated with a reduced fracture risk: A nationwide case-control study
    • Rejnmark L, Vestergaard P, Mosekilde L,. Treatment with β-blockers, ACE inhibitors, and calcium-channel blockers is associated with a reduced fracture risk: a nationwide case-control study. J Hypertens 2006; 24: 581-9.
    • (2006) J Hypertens , vol.24 , pp. 581-589
    • Rejnmark, L.1    Vestergaard, P.2    Mosekilde, L.3
  • 18
    • 22544468809 scopus 로고    scopus 로고
    • Estimating medication persistency using administrative claims data
    • Sikka R, Xia F, Aubert RE,. Estimating medication persistency using administrative claims data. Am J Manag Care 2005; 11: 449-57.
    • (2005) Am J Manag Care , vol.11 , pp. 449-457
    • Sikka, R.1    Xia, F.2    Aubert, R.E.3
  • 20
    • 61849096094 scopus 로고    scopus 로고
    • Improving the prediction of medication compliance: The example of bisphosphonates for osteoporosis
    • Curtis JR, Xi J, Westfall AO, Cheng H, Lyles K, Saag KG, et al. Improving the prediction of medication compliance: the example of bisphosphonates for osteoporosis. Med Care 2009; 47: 334-41.
    • (2009) Med Care , vol.47 , pp. 334-341
    • Curtis, J.R.1    Xi, J.2    Westfall, A.O.3    Cheng, H.4    Lyles, K.5    Saag, K.G.6
  • 21
    • 79251519614 scopus 로고    scopus 로고
    • World Health Organization
    • World Health Organization. Fracture risk assessment tool. 2012. URL: http://shef.ac.uk/FRAX.
    • (2012) Fracture Risk Assessment Tool
  • 22
  • 23
    • 58449083793 scopus 로고    scopus 로고
    • Identification and validation of vertebral compression fractures using administrative claims data
    • Curtis JR, Mudano AS, Solomon DH, Xi J, Melton ME, Saag KG,. Identification and validation of vertebral compression fractures using administrative claims data. Med Care 2009; 47: 69-72.
    • (2009) Med Care , vol.47 , pp. 69-72
    • Curtis, J.R.1    Mudano, A.S.2    Solomon, D.H.3    Xi, J.4    Melton, M.E.5    Saag, K.G.6
  • 24
    • 78650962009 scopus 로고    scopus 로고
    • Estimating bisphosphonate use and fracture reduction among US women aged 45 years and older, 2001-2008
    • Siris ES, Pasquale MK, Wang Y, Watts NB,. Estimating bisphosphonate use and fracture reduction among US women aged 45 years and older, 2001-2008. J Bone Miner Res 2011; 26: 3-11.
    • (2011) J Bone Miner Res , vol.26 , pp. 3-11
    • Siris, E.S.1    Pasquale, M.K.2    Wang, Y.3    Watts, N.B.4
  • 25
    • 34547670103 scopus 로고    scopus 로고
    • Adherence to lipid-lowering therapy and the use of preventive health services: An investigation of the healthy user effect
    • Brookhart MA, Patrick AR, Dormuth C, Avorn J, Shrank W, Cadarette SM, et al. Adherence to lipid-lowering therapy and the use of preventive health services: an investigation of the healthy user effect. Am J Epidemiol 2007; 166: 348-54.
    • (2007) Am J Epidemiol , vol.166 , pp. 348-354
    • Brookhart, M.A.1    Patrick, A.R.2    Dormuth, C.3    Avorn, J.4    Shrank, W.5    Cadarette, S.M.6
  • 26
    • 79960028739 scopus 로고    scopus 로고
    • The association between statin use and outcomes potentially attributable to an unhealthy lifestyle in older adults
    • Patrick AR, Shrank WH, Glynn RJ, Solomon DH, Dormuth CR, Avorn J, et al. The association between statin use and outcomes potentially attributable to an unhealthy lifestyle in older adults. Value Health 2011; 14: 513-20.
    • (2011) Value Health , vol.14 , pp. 513-520
    • Patrick, A.R.1    Shrank, W.H.2    Glynn, R.J.3    Solomon, D.H.4    Dormuth, C.R.5    Avorn, J.6
  • 28
    • 33846123697 scopus 로고    scopus 로고
    • Relationship between adherence to evidence-based pharmacotherapy and long-term mortality after acute myocardial infarction
    • Rasmussen JN, Chong A, Alter DA,. Relationship between adherence to evidence-based pharmacotherapy and long-term mortality after acute myocardial infarction. JAMA 2007; 297: 177-86.
    • (2007) JAMA , vol.297 , pp. 177-186
    • Rasmussen, J.N.1    Chong, A.2    Alter, D.A.3
  • 29
    • 79951673238 scopus 로고    scopus 로고
    • Adherence to osteoporosis drugs and fracture prevention: No evidence of healthy adherer bias in a frail cohort of seniors
    • Cadarette SM, Solomon DH, Katz JN, Patrick AR, Brookhart MA,. Adherence to osteoporosis drugs and fracture prevention: no evidence of healthy adherer bias in a frail cohort of seniors. Osteoporos Int 2011; 22: 943-54.
    • (2011) Osteoporos Int , vol.22 , pp. 943-954
    • Cadarette, S.M.1    Solomon, D.H.2    Katz, J.N.3    Patrick, A.R.4    Brookhart, M.A.5


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.